Protalix BioTherapeutics (PLX) Revenue Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 233.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 233.73% |
| Dec 31, 2025 | -49.93% |
| Sep 30, 2025 | -0.60% |
| Jun 30, 2025 | 16.21% |
| Mar 31, 2025 | 169.82% |
| Dec 31, 2024 | 73.74% |
| Sep 30, 2024 | 73.60% |
| Jun 30, 2024 | -61.59% |
| Mar 31, 2024 | -60.91% |
| Dec 31, 2023 | 21.69% |
| Sep 30, 2023 | -27.06% |
| Jun 30, 2023 | 300.72% |
| Mar 31, 2023 | -40.39% |
| Dec 31, 2022 | 0.80% |
| Sep 30, 2022 | 17.66% |
| Jun 30, 2022 | 36.19% |
| Mar 31, 2022 | 42.09% |
| Dec 31, 2021 | -56.15% |
| Sep 30, 2021 | 11.71% |
| Jun 30, 2021 | -41.40% |
| Mar 31, 2021 | -47.70% |
| Dec 31, 2020 | 39.46% |
| Sep 30, 2020 | -24.27% |
| Jun 30, 2020 | -10.45% |
| Mar 31, 2020 | 107.36% |
| Dec 31, 2019 | 696.07% |
| Sep 30, 2019 | 2,049.02% |
| Jun 30, 2019 | 510.52% |
| Mar 31, 2019 | 129.28% |
| Dec 31, 2018 | -2.44% |
| Sep 30, 2018 | -91.19% |
| Jun 30, 2018 | -68.45% |
| Mar 31, 2018 | 176.61% |
| Dec 31, 2017 | -13.50% |
| Sep 30, 2017 | 61.16% |
| Jun 30, 2017 | 259.41% |
| Mar 31, 2017 | 142.42% |
| Sep 30, 2016 | 249.55% |
| Jun 30, 2016 | 32.41% |
| Mar 31, 2016 | -59.87% |
| Mar 31, 2015 | -74.73% |
| Mar 31, 2014 | 87.67% |
| Dec 31, 2013 | -792.49% |
| Sep 30, 2013 | -38.67% |
| Jun 30, 2013 | -91.33% |
| Mar 31, 2013 | -7.59% |
| Dec 31, 2012 | -50.38% |
| Sep 30, 2012 | 228.98% |
| Jun 30, 2012 | 3,317.93% |
| Mar 31, 2012 | -6.47% |
| Dec 31, 2011 | 100.85% |
| Sep 30, 2011 | -64.45% |
| Jun 30, 2011 | -33.04% |